Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2020 Sep 18;21(2):97–105. doi: 10.1016/j.clml.2020.09.003

Figure 2. Treatment Effects on Skindex-29 and FACT-G.

Figure 2.

Abbreviations: C = cycle; FACT-G = Functional Assessment of Cancer Therapy-General; MOG = mogamulizumab; SEM = standard error of the mean; VOR = vorinostat.

*P<.05.

aAdjusted mixed model contained arm, visits, treatment visit interaction, baseline value of outcome, age group (<65 or ≥65 years), gender, region, race category (Black or African American, White, Other), CCR4 expression status, disease subtypes (mycosis fungoides or Sézary syndrome), disease stage (IB and II versus III or IV), and compartment involvement (blood involvement or no blood involvement).